Watson Pharmaceuticals, Inc. Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other May 1 Calls Today's Calls

Call Details Watson Pharmaceuticals, Inc. Earnings Conference Call (Q1 2008) Thu, May 1, 2008, 8:30 am Eastern Listen to the archived event audio About Watson Pharmaceuticals, Inc. (NYSE:WPI) Watson Pharmaceuticals, Inc. engages in the development, manufacture, marketing, and distribution of branded and generic pharmaceutical products in the United States. The company’s products are used in various therapeutic areas, which include central nervous system, nephrology, hormones and synthetic substitutes, cardiovascular, and other areas. It operates in three segments: Generic, Brand, and Distribution. The Generic segment manufactures and sells generic products for various therapeutic classes, including anti-depressant, anti-hypertensive, anti-diabetic, anti-hypertensive, analgesic, oral contraceptives, analgesic, and hormone replacement products. The Brand segment principally offers products for male hormone replacement, hematinic, overactive bladder, and prostate cancer therapeutics, as well as specialty products that focus on urology and nephrology. The Distribution segment distributes primarily generic pharmaceutical products to independent pharmacies; alternate care providers, such as hospitals, nursing homes, and mail order pharmacies; and pharmacy chains. This segment also distributes generic products and certain selective brand products to physicians’ offices. As of December 31, 2007, Watson Pharmaceuticals marketed approximately 150 generic pharmaceutical products and 27 brand pharmaceutical products. The company was founded in 1983 and is based in Corona, California. More Info: Quote | Chart | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings